First impressions of cardiovascular calcification treatment in hemodialysis patients with a new dialysis fluid containing sodium thiosulphate (STS)

International Journal of Artificial Organs

Volumn 37, Issue 4, 2014, Pages 308-314

  Yonova, Diana Hristova ^a   Vazelov, Evgueniy S ^a   Trendafilov, Ivan I ^a   Stoinova, Veselka V ^a   Nedevska, Mariya T ^a   Antonov, Simeon A ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Cardiovascular calcification (CVC); Coronary arteries; Dinatrium ethylene diamine tetra acetic acid (DNEDTA); Hemodialysis treatment; Sodium thiosulfate (STS)

Indexed keywords

AMINES; BIOMINERALIZATION; BONE; CALCIUM; CALCIUM COMPOUNDS; COMPUTERIZED TOMOGRAPHY; DIALYSIS; ETHYLENE; HEMODIALYZERS; PATHOLOGY;

CARDIOVASCULAR CALCIFICATION; CORONARY ARTERIES; DIALYSIS FLUIDS; DINATRIA ETHYLENE DIAMINE TETRA-ACETIC ACID; HAEMODIALYSIS; HEMODIALYSIS PATIENT; HEMODIALYSIS TREATMENT; SODIUM THIOSULFATE; SODIUM THIOSULPHATE; SPIRAL COMPUTED TOMOGRAPHIES;

SODIUM COMPOUNDS;

ACETIC ACID DERIVATIVE; C REACTIVE PROTEIN; DIALYSIS FLUID; DINATRIUM ETHYLENE DIAMINE TETRAACETIC ACID; FETUIN A; GLUCOSE; MALONALDEHYDE; SODIUM THIOSULFATE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CALCIUM CHELATING AGENT; EDETIC ACID; HEMODIALYSIS FLUID; THIOSULFATE;

AGATSTON SCORE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL CALCIFICATION; BONE DENSITOMETRY; BONE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; ELECTROCARDIOGRAPHY; ELECTROLYTE BALANCE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; LIVER FUNCTION; OXIDATIVE STRESS; PILOT STUDY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; BLOOD; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; RENAL REPLACEMENT THERAPY; TIME; TREATMENT OUTCOME; VASCULAR CALCIFICATION;

BIOLOGICAL MARKERS; CALCIUM CHELATING AGENTS; CORONARY ARTERY DISEASE; EDETIC ACID; HEMODIALYSIS SOLUTIONS; HUMANS; PILOT PROJECTS; RENAL DIALYSIS; THIOSULFATES; TIME FACTORS; TREATMENT OUTCOME; VASCULAR CALCIFICATION;

EID: 84900464956     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000309     Document Type: Article

References (20)

1. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004;95:560-567.
2. Moe SM, Chen NX. Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis. Pediatr Nephrol. 2003;18(10):969-975.
3. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007; 71(5):438-441.
4. Block GA, Klassen PS, Lazarus JM. Mineral metabolism mortality and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208-2218.
5. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol. 2004; 15(6):1392-1401.
6. Levin NW, Hoenich NA. Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr Opin Nephrol Hypertens. 2001;10(5):563-568.
7. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet. 2003;361(9360):827-833.
8. Torres PU, Prié D, Molina-Blétry V, Beck L, Silve C, Friedlander G. Klotho: an antiaging protein involved in mineral and vitamin D metabolism. Kidney Int. 2007;71(8):730-737.
9. Moe SM, Reslerova M, Ketteler M, et al. Role of calcification inhibitors in pathogenesis of vascular calcification in CKD. Kidney Int. 2005;67:2295-2304.
10. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342 (20):1478-1483.
11. Chertow GM. Slowing the progression of vascular calcification in hemodialysis. J Am Soc Nephrol. 2003;14(9)(Suppl 4):S310-S314.
12. Guerra G, Shah RC, Ross EA. Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report. Nephrol Dial Transplant. 2005;20(6): 1260-1262.
13. Yatzidis H. Successful sodium thiosulphate treatment for recurrent calcium urolithiasis. Clin Nephrol. 1985;23(2):63-67.
14. Kyriakopoulos G, Kontogianni K. Sodium thiosulfate treatment of tumoral calcinosis in patients with end-stage renal disease. Ren Fail. 1990;12(4):213-219.
15. Papadakis JT, Patrikarea A, Digenis GE, et al. Sodium thiosulfate in the treatment of tumoral calcifications in a hemodialysis patient without hyperparathyroidism. Nephron. 1996;72(2):308-312.
16. Cicone JS, Petronis JB, Embert CD, Spector DA. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis. 2004;43(6):1104-1108.
17. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S. Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int. 2008;74(11):1444-1453.
18. Shea M, Koziol JA, Howell SB. Kinetics of sodium thiosulfate, a cisplatin neutralizer. Clin Pharmacol Ther. 1984;35(3): 419-425.
19. Brucculeri M, Cheigh J, Bauer G, Serur D. Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial. 2005;18(5):431-434.
20. Braverman B, Ivankovich AD, Shah G. Thiosulfate pharmacokinetics in normal and anuric dogs. Proc Soc Exp Biol Med. 1982;170(3):273-280.